1:2 Stock Split Coming: Pharma Giant To Subdivide Shares On April 25; Buy Or Wait for A Breakdown?

With its headquarters located in Surat, Ami Organics is a research and development (R&D)-driven manufacturer of specialty chemicals that specializes in the development and production of cutting-edge pharmaceutical intermediates for regulated and generic active pharmaceutical ingredients (APIs) and chemicals for New Chemical Entities (NCE). Other specialty chemicals include methyl salicylate, parabens and paraben formulations, semiconductor chemicals, electrolyte additives, and specific key starting materials (KSM) for the fine chemicals, agrochemical, and cosmetics industries. In addition to being the first Indian firm outside of China to lead the innovative creation of electrolyte additives globally, Ami Organics is the market leader for a number of significant intermediates worldwide. With a market valuation of Rs 9,994.35 Cr, Ami Organics' shares closed 1.85% higher on the BSE on Friday at Rs 2441.55 a share. On (05/02/2025), 2025, the pharmaceutical stock hit a 52-week high of Rs 2,643.50, and on (04/06/2024), it hit a 52-week low of Rs 1,014.45.

Ami Organics Stock Split Date

"Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Company has fixed Friday, April 25, 2025 as the "Record Date" for determining entitlement of equity shareholders for the purpose of for split/ sub-division of existing equity shares of the Company, such that 1 (one) equity share having face value of Rs. 10/- (Rupees ten only) each, fully paid-up, will be sub-divided into 2 (Two) equity shares having face value of Rs. 5/- (Rupees Five only) each, fully paid up, ranking pari-passu in all respects, which was approved by the members through Postal Ballot on March 26, 2025 as already intimated to the Stock Exchanges vide our letter dated March 27, 2025," said Ami Organics in a stock exchange filing on Friday.

Ami Organics News

"We hereby inform that in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and in accordance with the Company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons ("Code"), the Trading Window for dealing in the securities of the Company will remain closed for all Designated Persons including their immediate relatives and specified connected persons of the Company, with effect from Tuesday, April 1, 2025 for the purpose of consideration of Audited Financial Results for the fourth quarter and year ending on March 31, 2025. The Trading Window shall open 48 hours after the declaration of Audited Financial Results for the fourth quarter and year ending on March 31, 2025. The date of meeting of the Board of Directors, for approval and declaration of the Audited Financial Results of the Company for the fourth quarter and year ending on March 31, 2025 shall be informed in due course," Ami Organics informed stock exchanges.

Ami Organics Financials

In comparison to the Rs 17.81 crore reported in Q3 FY24, the company's consolidated net profit climbed 155.13% to Rs 45.44 crore in Q3 FY25. In the December 2024 quarter, revenue from operations increased 65.21% to Rs 274.98 crore from Rs 166.44 crore in the same quarter of FY24. During Q3FY25, total expenses jumped by 45.87% YoY to Rs 213.32 crore. In comparison to the Rs 237.03 crore reported in Q3 FY24, the profit before tax in Q3 FY25 was Rs 633.34 crore, representing a rise of 167.19%. In comparison to Q3 FY24, when EBITDA was Rs 26.50 crore, it increased by 159.24% to Rs 68.70 crore in Q3 FY25. Compared to the 15.9% reported in the same quarter of the previous year, the EBITDA margin increased by 25% during the quarter that ended in December 2024.

Ami Organics Share Price Target

"Ami Organics stock price is bearish on the Daily charts with strong resistance at 2532. A Daily close below support of 2038 could lead to a target of 1837 in the near term," stated A R Ramachandran, Independent Research Analyst.

Disclaimer

The recommendations made above are by market analysts and are not advised by either the author, nor Greynium Information Technologies. The author, nor the brokerage firm nor Greynium would be liable for any losses caused as a result of decisions based on this write-up. Goodreturns.in advises users to consult with certified experts before making any investment decision.